Table 1.

Characteristics of patients at baseline.

	Leuprolide (N = 48)	Triptorelin (N = 62)	p-value
Age (years); [median (Q1–Q3)]	7.5 (7.1–7.8)	7.5 (7.1–7.8)	0.784
Weight (kg); [median (Q1–Q3)]	27.8 (24.0–30.8)	28.7 (24.8–32.7)	0.273
Height (cm); [median (Q1–Q3)]	127.9 (122.8–132.8)	127.5 (121.9–132.1)	0.607
PAH (cm); [median (Q1–Q3)]	150.3 (145.6–154.7)	149.4 (145.8–155.4)	0.938
Bone age (years); [median (Q1–Q3)]	9.6 (9.0–10.3)	9.4 (8.6–10.5)	0.971
FSH baseline (mUI/ml)	2.85 (1.67–3.77)	3.11 (2.00–5.27)	0.263
FSH peak (mUI/ml)	14.1 (11.0–18.4)	13.3 (10.9–15.8)	0.237
LH baseline (mUI/ml)	0.22 (0.10–0.44)	0.35 (0.30–1.42)	<0.001
LH peak (mUI/ml)	6.0 (4.0–13.3)	10.6 (6.5–23.3)	0.006
E2 (pg/ml)	12.0 (5.0–19.5)	7.5 (5.0–18.6)	0.413
SMC (ng/ml)	277.0 (226.0–352.5)	263.5 (205.5–335.5)	0.518
Uterus Longitudinal diameter (mm)	36.5 (32.0–43.0)	38.7 (34.0–43.0)	0.381
Ovarian right (cc)	1.9 (1.2–3.4)	2.0 (1.5–3)	0.455
Ovarian left (cc)	2.0 (1.2–3.3)	1.8 (1.5–2.6)	0.677